Radius Health (RDUS) Says Positive Results from 6-month Interim Analysis of ACTIVExtend Trial Were Published in Mayo Clinic Proceedings
Tweet Send to a Friend
Radius Health, Inc. (Nasdaq: RDUS) today announced that positive results from a planned 6-month interim analysis of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
